Scihuhuan平台已收录预计检索 <10 秒
Safety, Pharmacokinetics and Pharmacodynamics of the GLP -1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
- 题目
- Safety, Pharmacokinetics and Pharmacodynamics of the GLP -1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study
- 作者
- Guo‐ping Yang, Ya‐xin Liu, Jin‐lian Xie, Shan Zeng, Jing Xiong, Wei Ling, Hai‐yan Zhang, Tao Su, Yu‐xiu Xu, Liang Huang, Thomas Holst‐Hansen, Sofie Bay, Hui‐ru Yan, Jie Huang, Ping Jin
- 发表年份
- 2026
- 期刊 / 来源
- Diabetes, Obesity and Metabolism
- 出版社
- Wiley
- 文献类型
- 学术文献
- 平台记录更新
- 2026-09-14 16:18:53
本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。
引用格式
同来源相关文献
Hepatic thyroid hormone receptor-β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitis2025 · Diabetes, Obesity and MetabolismOral Butyrate Reduces Progression of Kidney Damage in an L- NAME -Induced Diabetic Kidney Disease Mouse Model2026 · Diabetes, Obesity and MetabolismJoint Trajectories of Physical Activity and Depressive Symptoms and Incident Cardiometabolic Multimorbidity: A Multi-Cohort Study2026 · Diabetes, Obesity and MetabolismImpact of caloric restriction on diabetes remission in Korean adults with obesity (CREDO-K study)2025 · Diabetes, Obesity and MetabolismOptimizing cardiovascular health with a type 2 diabetes remission program: Ultraprocessed food-intake reduction, Mediterranean diet, chrononutrition and physical training—The DIABEPIC -2 pilot study2025 · Diabetes, Obesity and MetabolismEfficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24-week, randomized, open-label, multicenter trial2026 · Diabetes, Obesity and Metabolism